🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523419-12-00
Authorised Phase I

Multiple-Ascending Doses of 2-Methoxyestradiol in Healthy Non-Pregnant Female Participants.

2025-523419-12-00 · tracked via the Priya Life Science EU tracker
Sponsor
Laboratorios Leon Farma S.A.
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
29/09/2025
Enrollment target
60
Sites
Portugal

Condition studied

No medical condition.

Eligibility

Age group
18-64 years
Sex
Female
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523419-12-00 on CTIS ↗ ← All trials in the EU